Jeremy Albright, PhD, is a MISHC Statistician conducting statistical analyses for peer-reviewed research manuscripts that utilize MISHC data.
MISHC Meeting Summaries for Q4 2023
Did you miss a meeting or do you need a refresher? Read our Q4 2023 meeting summaries.
New MiTVT2 Shared Decision Making Best Practice Protocol
Shared decision making is guideline-recommended for patients with valvular heart disease.
New Process for Report Distribution
The MISHC Coordinating Center will roll out a new process by which you will access your MISHC reports beginning with Q2 2023 reports.
New Best Practice Protocol - Post-TAVR Conduction System Abnormalities
A new Best Practice Protocol, “Post-TAVR Conduction System Abnormalities,” is now available on mishc.org.
MISHC Meeting Summaries for Q3 2023
Did you miss a meeting or do you need a refresher? Read our Q3 2023 meeting summaries.
2025 MISHC TAVR VBR Metrics Approved by Blue Cross Blue Shield of Michigan
The 2025 MISHC TAVR Value Based Recognition (VBR) Metrics have been approved by Blue Cross Blue Shield of Michigan and will be effective January 1st, 2024.
Process for confirming VBR site-specific measures:
Virtual Pre-Procedure Visits Have Ended
The Federal COVID-19 Public Health Emergency ended May 11th, 2023; virtual pre-procedure visits also ended. Please plan accordingly.
Reminder to Utilize the Contact Update Form to Update Contacts
Please use the Contact Update Form on mishc.org to add, update, or remove contacts from your site.